| Everest Organics Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524790 |
NSE Symbol : - |
P/E(TTM) : 42.85 |
|
ISIN Demat : INE334C01029 |
Div & Yield% : 0.00 |
EPS(TTM) : 5.27 |
|
Book Value(₹) : 79.69 |
Market Cap(₹Cr) : 225.21 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 48.43 | 48.75 | 42.59 | 51.00 | 53.81 | 40.93 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 48.43 | 48.75 | 42.59 | 51.00 | 53.81 | 40.93 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.42 | 0.16 | 0.25 | 0.29 | 0.55 | 0.22 |
| Total Income | 48.85 | 48.91 | 42.84 | 51.29 | 54.36 | 41.15 |
| Total Expenditure | 44.10 | 42.05 | 39.05 | 45.87 | 49.38 | 37.50 |
| PBIDT | 4.75 | 6.86 | 3.79 | 5.42 | 4.99 | 3.65 |
| Interest | 1.63 | 2.76 | 1.23 | 1.23 | 1.31 | 1.15 |
| PBDT | 3.12 | 4.10 | 2.56 | 4.19 | 3.68 | 2.51 |
| Depreciation | 1.59 | 1.93 | 1.52 | 1.52 | 1.52 | 1.56 |
| Tax | 0.73 | 0.51 | 0.48 | 0.91 | 0.36 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.32 | -0.97 | 0.20 | 0.61 | 0.40 | -1.96 |
| Reported Profit After Tax | 1.11 | 2.63 | 0.36 | 1.16 | 1.41 | 2.91 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 1.11 | 2.63 | 0.36 | 1.16 | 1.41 | 2.91 |
| EPS (Unit Curr.) | 1.15 | 2.69 | 0.37 | 1.19 | 1.45 | 2.30 |
| EPS (Adj) (Unit Curr.) | 1.15 | 2.69 | 0.37 | 1.19 | 1.45 | 2.30 |
| Calculated EPS (Unit Curr.) | 1.15 | 2.71 | 0.37 | 1.19 | 1.45 | 3.00 |
| Calculated EPS (Adj) (Unit Curr.) | 1.15 | 2.71 | 0.37 | 1.19 | 1.45 | 3.00 |
| Calculated EPS (Ann.) (Unit Curr.) | 4.59 | 10.83 | 1.47 | 4.76 | 5.79 | 12.00 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 4.59 | 10.83 | 1.47 | 4.76 | 5.79 | 12.00 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 9.71 | 9.71 | 9.71 | 9.71 | 9.71 | 9.71 |
| Reserve & Surplus | 66.88 | 65.77 | 63.15 | 62.80 | 61.64 | 60.24 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 9.81 | 14.07 | 8.90 | 10.63 | 9.27 | 8.92 |
| PBDTM(%) | 6.44 | 8.41 | 6.01 | 8.22 | 6.84 | 6.13 |
| PATM(%) | 2.29 | 5.39 | 0.85 | 2.27 | 2.62 | 7.11 |
